Adamis Pharmaceuticals Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.51%159.460.7%$1249.15m
LLYEli Lilly & Co. -2.35%325.121.1%$1080.07m
ABBVAbbVie, Inc. -1.66%137.961.9%$846.26m
PFEPfizer Inc. -2.66%41.950.9%$782.01m
BMYBristol-Myers Squibb Co. -1.37%69.281.0%$741.52m
MRKMerck & Co., Inc. -0.27%87.200.7%$695.74m
AZNAstraZeneca Plc 0.59%55.241.0%$388.51m
ALNYAlnylam Pharmaceuticals, Inc. -3.66%194.968.2%$216.59m
GSKGSK Plc 0.23%30.070.3%$209.00m
NVSNovartis AG -0.86%75.390.2%$199.19m
HZNPHorizon Therapeutics Plc -4.98%64.515.4%$179.31m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -4.06%331.973.9%$176.85m
SRPTSarepta Therapeutics, Inc. -3.09%111.2712.4%$137.35m
AKROAkero Therapeutics, Inc. -2.48%38.290.0%$130.86m

Company Profile

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.